This morning I received a call from a patient who had been referred to us by a happy patient. She had problems with both her knees and her left hip. During her consultation, our specialist told her that we do not recommend treating 3 joints at the same time because generally we cannot achieve enough of a robust harvest of cells to produce a good result. We explained that we measure the number of cells that are harvested and even though we are able to achieve concentrations of stem cells that are between 5 to 7 times with our proprietary laboratory processing, it would still be unlikely that we would have enough cells based on our outcome data.
This patient decided to talk to another stem cell provider and was told that they could treat all three joints in the same session because the number of stem cells in fat (adipose tissue) was up to 40 times greater than from bone marrow. She went ahead with this doctor three months ago and called me today to tell me that she is not any better. I explained that I’m not surprised based on our outcome studies and actual laboratory testing of real stem cells harvested from adipose tissues. The patient asked me if she could have a special discount because she spent so much with the other doctor with no result. Now I had a real dilemma because as much as I want to help her get what she needs, I just couldn’t justify giving her a discount, especially since she ignored our advice and outsmarted herself. This is a real problem for those of us who work hard to scientifically verify our methods and procedures as consumers cannot distinguish the differences. So many patients are undergoing treatment by these clinics whose physicians are not true specialists in regenerative orthopedics. She told me that she is going to have to save up to afford the procedure with us in the future.
So this brings up the issue of how we can educate consumers about the various methods of stem cell treatments for orthopedics. Unfortunately, the FDA and FTC do not regulate or enforce violators of established and published regulations and claims. The bottom line is this; adipose derived cells are hugely exaggerated in numbers because they are easily mistaken from other cells and are estimated. In addition, the cells that are harvested are considered Stromal Vascular Fraction (SVF) that are very difficult for them to differentiate into cartilage, ligament, tendon and bone tissue unlike marrow derived cells. Marrow derived cells have a wide body of research that verifies the differentiation preferences and has been used for more than 10 years for orthopedic conditions.
To learn how to tell a good clinic from bad, please click on this link and scroll through the articles: http://www.regenexx.com/?s=stem+cell+clinics
To learn more about adipose tissue vs marrow derived, please click on: http://www.regenexx.com/?s=adipose
Yours in Health,
Dr. Norman Deitch